Laddar...

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer

Despite surgical and chemotherapeutic advances over the past few decades, the prognosis for ovarian cancer remains very poor. Although cyclin-dependent kinase (CDK) 9 has an established pathogenic role in various cancers, its function in ovarian cancer remains poorly defined. The purpose of this stu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:FASEB J
Huvudupphovsmän: Wang, Jinglu, Dean, Dylan C., Hornicek, Francis J., Shi, Huirong, Duan, Zhenfeng
Materialtyp: Artigo
Språk:Inglês
Publicerad: Federation of American Societies for Experimental Biology 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463912/
https://ncbi.nlm.nih.gov/pubmed/30726104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201801789RR
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!